Found: 13
Select item for more details and to access through your institution.
Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 6, p. 1346, doi. 10.1002/cpt.3216
- By:
- Publication type:
- Article
Venetoclax in biomarker‐selected multiple myeloma patients: Impact of exposure on clinical efficacy and safety.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3222
- By:
- Publication type:
- Article
Alternatives to rifampicin: A review and perspectives on the choice of strong CYP3A inducers for clinical drug–drug interaction studies.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2075, doi. 10.1111/cts.13357
- By:
- Publication type:
- Article
Venetoclax exposure‐efficacy and exposure‐safety relationships in patients with treatment‐naïve acute myeloid leukemia who are ineligible for intensive chemotherapy.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 2, p. 269, doi. 10.1002/hon.2964
- By:
- Publication type:
- Article
Upadacitinib pharmacokinetics and exposure‐response analyses of efficacy and safety in psoriatic arthritis patients – Analyses of phase III clinical trials.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 1, p. 267, doi. 10.1111/cts.13146
- By:
- Publication type:
- Article
Exposure‐Response Analyses for Upadacitinib Efficacy in Subjects With Atopic Dermatitis—Analyses of Phase 2b Study to Support Selection of Phase 3 Doses.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 5, p. 628, doi. 10.1002/jcph.1782
- By:
- Publication type:
- Article
Integrated Mechanistic Model of Minimal Residual Disease Kinetics With Venetoclax Therapy in Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 424, doi. 10.1002/cpt.2005
- By:
- Publication type:
- Article
Model‐Informed Dosing of Venetoclax in Healthy Subjects: An Exposure−Response Analysis.
- Published in:
- CTS: Clinical & Translational Science, 2019, v. 12, n. 6, p. 625, doi. 10.1111/cts.12665
- By:
- Publication type:
- Article
Optimizing venetoclax dose in combination with low intensive therapies in elderly patients with newly diagnosed acute myeloid leukemia: An exposure-response analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Hepatitis C Virus-Infected Cirrhotic and Non-cirrhotic Patients: Analyses Across Nine Phase III Studies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Population Pharmacokinetics of Paritaprevir, Ombitasvir, and Ritonavir in Japanese Patients with Hepatitis C Virus Genotype 1b Infection.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Exposure-Response Relationship for Ombitasvir and Paritaprevir/Ritonavir in Hepatitis C Virus Subgenotype 1b-Infected Japanese Patients in the Phase 3 Randomized GIFT-I Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Estimating HIV-1 Fitness Characteristics from Cross-Sectional Genotype Data.
- Published in:
- PLoS Computational Biology, 2014, v. 10, n. 11, p. 1, doi. 10.1371/journal.pcbi.1003886
- By:
- Publication type:
- Article